Commitments and Contingencies (Details 3) (Byrne Medical Business, Medivators subsidiary, USD $)	Jul. 31, 2013	Aug. 02, 2011
Byrne Medical Business \| Medivators subsidiary
Acquisitions Payable
Value of common stock issued as a part of purchase price consideration		$ 10,000,000
Aggregate value of the stock consideration threshold		10,000,000
Revised estimated fair value of payable	$ 45,000

Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity.

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 141

-Paragraph 51

-Subparagraph d

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number 99-12

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Name:	us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant